We have previously shown that the naturally occurring levomorphine at a subanalgesic picomolar dose pretreated i.t. induces antianalgesia against levo-morphine-produced antinociception. We now report that the synthetic stereo-enantiomer dextro-morphine, even at an extremely low femtomolar dose, induces antianalgesia against levo-morphine-produced antinociception using the tail-flick (TF) test in male CD-1 mice. Intrathecal pretreatment with dextro-morphine (33 fmol) timedependently attenuated the i.t. levo-morphine-produced TF inhibition for 4 h and returned to the preinjection control level at 24 h. Intrathecal pretreatment with dextro-morphine (0.3-33 fmol), which injected alone did not affect the baseline TF latency, dose-dependently attenuated the TF inhibition produced by i.t.-administered levo-morphine (3.0 nmol). The ED 50 value for dextro-morphine to induce antianalgesia was estimated to be 1.07 fmol, which is 71,000-fold more potent than the ED 50 value of levo-morphine, indicating the high stereoselective action of dextro-morphine over levo-morphine for the induction of antianalgesia. Like levo-morphine, the dextro-morphineinduced antianalgesia against levo-morphine-produced TF inhibition was dose-dependently blocked by the nonopioid dextro-naloxone and its stereo-enantiomer levo-naloxone, a nonselective -opioid receptor antagonist. The antianalgesia induced by levo-morphine and dextro-morphine is reversed by the pretreatment with the glial inhibitor propentofylline (3.3-65 nmol), indicating that the antianalgesia is mediated by glial stimulation. The findings strongly indicate that the antianalgesia induced by levo-morphine and dextro-morphine is mediated by the stimulation of a novel nonopioid receptor on glial cells.Naturally occurring levo-morphine, which is isolated from the juice of the opium poppy, Papaver somniferum, is stereochemically identified as a levorotatory isoform of morphine. levo-Morphine produces potent analgesic and other major pharmacological effects, which are mainly mediated by the stimulation of -opioid receptors. The synthetic dextro-enantiomer of levo-morphine has minimal activity in the -opioid receptor binding assay, the electrically stimulated guinea pig ileum assay, and the inhibition of adenylate cyclase activity in the neuroblastoma ϫ glioma hybrid cell homogenates, indicating that it does not interact with -opioid receptors (Jacquet et al., 1977). Unlike levo-morphine, which produces potent levo-naloxone reversible analgesia, dextro-morphine microinjected into the periaqueductal gray in rats produces minimal analgesia (Jacquet et al., 1977). In the present study, i.t. pretreatment with dextro-morphine, which injected alone does not affect baseline nociceptive latency, attenuates the antinociception produced by i.t.-administered levo-morphine. The phenomenon of the attenuation of levo-morphineproduced analgesia by dextro-morphine has been defined as antianalgesia (Wu et al., 2004b).Nonselective -opioid receptor antagonist levo-naloxone and nonopioid receptor ant...